Share

Impact of the InMed compounds on the endocannabinoid system of human keratinocytes and on their biological functions

 

Project objectives

The project aims to thoroughly investigate the potential role of some chemical compounds from InMed Pharmaceuticals in modulating the various elements that make up the endocannabinoid system in human keratinocytes, in order to use them as new therapeutic approaches for various skin disorders including tumors, psoriasis, atopic dermatitis, acne vulgaris, seborrhea, and pruritus. 

Start and end date

2019 - 2021

Project Manager

Prof. Mauro Maccarrone 

Coordinating institution of the project

Università Campus Bio-Medico di Roma

Other Institutions involved

University of Teramo

Funding source(s).

InMed Pharmaceuticals Inc. (Canada)

QUICK LINKS
magnifiercrossmenuchevron-downchevron-leftchevron-right